🔎 Trials Near Me

Home › Major Depressive Disorder › Florida › Brandon

Major Depressive Disorder clinical trials in Brandon, FL

6 studies for Major Depressive Disorder are looking for participants at sites in and around Brandon (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

RecruitingPhase 3
  • Clinical Research of Brandon, Brandon
Ages 18 to 74 · All sexes · Updated Sep 25, 2026 · NCT06559306

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

RecruitingPhase 3
  • Equipath Health and Research Tampa Bay, Llc, Riverview · 6 mi away
Ages 18 to 74 · All sexes · Updated Sep 8, 2026 · NCT07076407

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

RecruitingPhase 2
  • EquiPath Health and Research Tampa Bay, LLC, Riverview · 6 mi away
Ages 18 to 64 · All sexes · Updated Jul 27, 2026 · NCT07115329

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

RecruitingPhase 2
  • EquiPath Health & Research Tampa Bay, LLC /ID# 279128, Riverview · 6 mi away
Ages 18 to 65 · All sexes · Updated Jun 15, 2026 · NCT07276997

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

RecruitingPhase 2
  • Autobahn Site #108, Brandon
Ages 18 to 65 · All sexes · Updated Jan 20, 2026 · NCT06633016

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

RecruitingPhase 4
  • Clinical Research Site, Brandon
Ages 18 to 65 · All sexes · Updated Jan 23, 2025 · NCT06223880

Major Depressive Disorder trials in other cities

Other studies in Brandon

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.